Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sintezza Bioscience is a specialized biotechnology service provider based in Jerusalem, Israel, primarily serving the domestic life sciences and diagnostic markets. Founded in 2000, the company has established itself as a key infrastructure player by providing high-quality custom oligonucleotide and gene synthesis services. Sintezza operates as the exclusive Israeli representative for Integrated DNA Technologies (IDT), leveraging this partnership to offer a broad portfolio of genomic tools, including NGS library preparation and CRISPR reagents. Their service offering extends to molecular biology reagents, PCR solutions, and comprehensive sequencing support for academic and industrial clients. While the company does not maintain an internal therapeutic pipeline, its role as a primary supplier and service hub makes it a central figure in the Israeli biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sintezza.